Characterisation of a new chimeric ligand for galanin receptors : galanin(1-13)-[D-Trp(32)]-neuropeptide Y(25-36)amideSaar, K.; Mahlapuu, R.; Laidmäe, E.; Valkna, Andres; Kahl, U.; Karelson, E.; Langel, ÜloRegulatory peptides2001 / p. 15-19

Evaluation of transportan 10 in PEI mediated plasmid delivery assayKilk, K.; El-Andaloussi, S.; Jarver, P.; Meikas, A.; Valkna, Andres; Bartfai, T.; Kogerman, Priit; Metsis, Madis; Langel, ÜloJournal of controlled release2005 / 2, p. 511-523 https://pubmed.ncbi.nlm.nih.gov/15763630/

Internalisation of cell-penetrating peptides into tobacco protoplastsMäe, Maarja; Myrberg, Helena; Jiang, Yang; Paves, Heiti; Valkna, Andres; Langel, ÜloBiochimica et biophysica acta : biomembrans2005 / 2, p. 101-107 : ill https://pubmed.ncbi.nlm.nih.gov/15893512/

Prediction of cell-penetrating peptides using artificial neural networksDobchev, Dimitar A.; Mäger, Imre; Tulp, Indrek; Karelson, Gunnar; Tamm, Tarmo; Tämm, Kaido; Jänes, Jaak; Langel, Ülo; Karelson, MatiCurrent computer-aided drug design2010 / 2, p. 79-89

Regulation of transcription factor Gli activity using oligodeoxynucleotide decoy bound to Transportan 10Laur, Kristi; Langel, Ülo; Kogerman, Priit; Valkna, AndresSpetsai Summer School : Protein and their Networks - from specific to global analysis : Spetses, Greece, 7.09.2009-17.09.20092009 / ? p

Regulation of transcription factor GLI activity using oligodeoxynucleotide decoy with transportanLaur, Kristi; Langel, Ülo; Kogerman, Priit; Valkna, Andres3rd Intracellular Delivery of Therapeutic Molecules : from Bench to Bedside. 15 years of Cell-penetrating Peptides : from Molecular Mechanisms to the Clinic : Montpellier, France, 31.08.2009-2.09.20092009 / p. 42

Role of third intracellular loop of galanin receptor type 1 in signal transductionRezaei, K.; Saar, K.; Soomets, U.; Valkna, Andres; Nasman, J.; Zorko, M.; Akerman, K.; Schroeder, T.; Bartfai, T.; Langel, ÜloNeuropeptides2000 / p. 25-31